Efficacy of Goshajinkigan for Peripheral Neurotoxicity of Oxaliplatin in Patients with Advanced or Recurrent Colorectal Cancer

<table>Kaplan-Meier analysis of Grade 3 peripheral neuropathy in relation to the total dose of oxaliplatin. Group A, GJG; Group B, calcium gluconate (Ca) and magnesium sulfate (Mg); Group C, GJG + Ca/Mg; Group D, no therapy. <i>P</i>-values are for comparison to Group D with the log-rank test.</table>

Evidence-Based Complementary and Alternative Medicine

fig3

Figure 3

Figure 3: Efficacy of Goshajinkigan for Peripheral Neurotoxicity of Oxaliplatin in Patients with Advanced or Recurrent Colorectal Cancer 